Understanding Agilent Technologies Stocks – The Key Fundamentals to Consider

By Blake Campbell • Monday, August 25 15:20 • Permanent Link

Large-cap Industrials company Agilent Technologies has moved -2.4% so far today on a volume of 830,048, compared to its average of 1,781,787. In contrast, the S&P 500 index moved -0.0%.

Agilent Technologies trades -13.67% away from its average analyst target price of $137.57 per share. The 15 analysts following the stock have set target prices ranging from $120.0 to $165.0, and on average have given Agilent Technologies a rating of buy.

If you are considering an investment in A, you'll want to know the following:

Agilent Technologies's current price is 164.2% above its Graham number of $44.95, which implies that at its current valuation it does not offer a margin of safety
Agilent Technologies has moved -13.4% over the last year, and the S&P 500 logged a change of 15.1%
Based on its trailing earnings per share of 4.06, Agilent Technologies has a trailing 12 month Price to Earnings (P/E) ratio of 29.3 while the S&P 500 average is 29.3
A has a forward P/E ratio of 21.0 based on its forward 12 month price to earnings (EPS) of $5.65 per share
Its Price to Book (P/B) ratio is 5.5 compared to its sector average of 2.89
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Based in Santa Clara, the company has 18,000 full time employees and a market cap of $33.74 Billion. Agilent Technologies currently returns an annual dividend yield of 0.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.